Covid-19, ko kuma aka sani da 2019-nCoV ko SARS-CoV-2 virus, na dangin Coronavirus ne.Kamar yadda SARS-CoV-2 na cikin β genus Coronavirus yana da alaƙa da MERS-CoV da SARS-CoV - waɗanda kuma an ba da rahoton haifar da alamun cutar huhu a cikin cututtukan da suka gabata.An siffanta tsarin kwayoyin halitta na 2019-nCoV kuma an buga shi.[i] [ii] Babban sunadaran da ke cikin wannan kwayar cutar da wadanda aka gano a baya a cikin SARS-CoV ko MERS-CoV suna nuna kamanceceniya tsakanin su.
Sabon sabon nau'in kwayar cutar yana nufin cewa akwai rashin tabbas da yawa game da halayenta, saboda haka ya yi wuri don tantance ko tsire-tsire na ganye ko mahadi na iya ba da gudummawa a zahiri ga al'umma a matsayin wakilai na rigakafi ko a matsayin abubuwan da suka dace a cikin magungunan rigakafin cutar coronavirus. -19.Koyaya, saboda babban kamanni na Covid-19 tare da ƙwayoyin cuta na SARS-CoV da MERS-CoV da aka ruwaito a baya, binciken da aka buga a baya akan mahaɗan ganye, waɗanda aka tabbatar suna yin tasirin anti-coronavirus, na iya zama jagora mai mahimmanci don gano anti-coronavirus. tsire-tsire na ganye, waɗanda za su iya yin aiki da ƙwayar cuta ta SARS-CoV-2.
Bayan fashewar SARS-CoV, wanda aka fara ba da rahoto a farkon 2003[iii], masana kimiyya sun yi yunƙurin yin amfani da magungunan rigakafi da yawa akan SARS-CoV.Wannan ya sa gungun kwararru a kasar Sin suka tantance sama da 200 na ganyen magani na kasar Sin don ayyukan rigakafin cutar coronavirus.
Daga cikin waɗannan, tsantsa guda huɗu sun nuna matsakaici zuwa tasirin hanawa ga SARS-CoV - Lycoris radiata (Red Spider Lily), yaren Pyrrosia (a fern), Artemisia annua (Sweet wormwood) da Lindera tara (wani ɗanɗano mai ɗanɗano mai ɗanɗano ɗanɗano na dangin laurel). ).Sakamakon antiviral na waɗannan sun dogara da kashi kuma sun bambanta daga ƙananan ƙididdiga na tsantsa zuwa babba, bambanta ga kowane tsantsa na ganye.Musamman Lycoris radiata ya baje kolin aikin rigakafin ƙwayoyin cuta mafi ƙarfi akan nau'in ƙwayar cuta.[iv]
Wannan sakamakon ya yi daidai da na wasu ƙungiyoyin bincike guda biyu, waɗanda ke ba da shawarar cewa wani yanki mai aiki da ke cikin tushen Licorice, Glycyrrhizin, an tabbatar da yana da aikin anti-SARS-CoV ta hanyar hana kwafinsa.[v] [vi] A wani. Nazarin, Glycyrrhizin kuma ya nuna aikin rigakafin ƙwayar cuta lokacin da aka gwada shi don tasirin antiviral na in vitro akan 10 daban-daban na asibiti na SARS coronavirus.An gwada Baicalin - wani yanki na shuka Scuttelaria baicalensis (Skullcap) - kuma an gwada shi a cikin wannan binciken a ƙarƙashin yanayi guda kuma ya nuna maganin rigakafin cutar sankara na SARS. -1 virus in vitro a cikin binciken da ya gabata.[viii] [ix] Duk da haka ya kamata a lura cewa binciken da aka gano a cikin vitro bazai dace da in vivo ingancin asibiti ba.Wannan shi ne saboda kashi na baki na waɗannan wakilai a cikin ɗan adam bazai iya samun ƙwayar jini kamar wanda aka gwada a cikin vitro ba.
Lycorine ya kuma nuna tasirin antiviral a kan SARS-CoV.3 Rahotanni da yawa na baya sun nuna cewa Lycorine da alama yana da ayyukan rigakafi da yawa kuma an ba da rahoton cewa ya nuna aikin hanawa akan cutar Herpes Simplex (nau'in I) [x] da Poliomyelitis. virus kuma.[xi]
"Sauran ganyen da aka ruwaito sun nuna aikin rigakafin cutar SARS-CoV sune Lonicera japonica (Honeysuckle na Japan) da kuma tsiron Eucalyptus da aka fi sani da shi, da Panax ginseng (tushen) ta hanyar aikin sa na Ginsenoside-Rb1."[xii]
Shaidu daga binciken da aka ambata a baya da kuma wasu bincike na duniya da dama sun ba da rahoton cewa, yawancin kayan lambu na magani sun baje kolin ayyukan rigakafin cutar kanjamau [xiii] [xiv] kuma babban tsarin aikinsu ya kasance ta hanyar hana kamuwa da kwayar cutar kwayar cutar kwayar cuta.[xv] China. ya yi amfani da ganyayen magani na gargajiya na kasar Sin sosai don maganin SARS yadda ya kamata a lokuta da yawa.[xvi] Duk da haka, har yanzu babu wata kwakkwarar shaida kan tasirin magungunan ga masu cutar Covid-19.
Shin irin wannan tsantsar ciyawa na iya zama masu yuwuwar ƴan takara don haɓaka sabbin magungunan rigakafi don rigakafi ko maganin SARS?
GASKIYA: An rubuta wannan labarin don dalilai na bayanai kawai kuma ba a yi niyya don musanya shawarar ƙwararrun likita, ganewar asali ko magani ba.Idan kuna tunanin kuna iya samun alamun da ke da alaƙa da na Covid-19 ko wata cuta, kira likitan ku nan da nan.
[i] Zhou, P., Yang, X., Wang, X. et al., 2020. Barkewar cutar huhu da ke da alaƙa da sabon coronavirus mai yuwuwar asalin jemagu.Yanayin 579, 270-273 (2020).doi.org/10.1038/s41586-020-2012-7
[ii] Andersen, KG, Rambaut, A., Lipkin, WI, Holmes, EC da Garry, RF, 2020. Asalin kusancin SARS-CoV-2.Magungunan yanayi, shafi 1-3.
[iii] CDC SARS Response timeline.Akwai a https://www.cdc.gov/about/history/sars/timeline.htm.An shiga
[iv] Li, SY, Chen, C., Zhang, HQ, Guo, HY, Wang, H., Wang, L., Zhang, X., Hua, SN, Yu, J., Xiao, PG da Li, RS, 2005. Gano mahallin halitta tare da ayyukan antiviral akan coronavirus mai alaƙa da SARS.Binciken antiviral, 67 (1), shafi 18-23.
[v] Cinatl, J., Morgenstem, B. da Bauer, G., 2003. Glycyrrhizin, wani sashi mai aiki na tushen licorice da kwafi na SARS da ke hade da coronovirus.Lancet, 361 (9374), shafi na 2045-2046.
[vi] Hoever, G., Baltina, L., Michaelis, M., Kondratenko, R., Baltina, L., Tolstikov, GA, Doerr, HW da Cinatl, J., 2005. Ayyukan Antiviral na Glycyrrhizic Acid Abubuwan da aka samo SARS - Coronavirus.Jaridar magungunan magani, 48 (4), shafi 1256-1259.
[vii] Chen, F., Chan, KH, Jiang, Y., Kao, RYT, Lu, HT, Fan, KW, Cheng, VCC, Tsui, WHW, Hung, IFN, Lee, TSW da Guan, Y., 2004. In vitro mai saukin kamuwa na 10 na asibiti ware na SARS coronavirus zuwa zaba antiviral mahadi.Jaridar Clinical Virology, 31 (1), shafi 69-75.
[viii] Kitamura, K., Honda, M., Yoshizaki, H., Yamamoto, S., Nakane, H., Fukushima, M., Ono, K. da Tokunaga, T., 1998. Baicalin, mai hanawa na HIV-1 samar a cikin vitro.Binciken antiviral, 37 (2), shafi 131-140.
[ix] Li, BQ, Fu, T., Dongyan, Y., Mikovits, JA, Ruscetti, FW da Wang, JM, 2000. Flavonoid baicalin yana hana kamuwa da cutar HIV-1 a matakin shigar da kwayar cutar.Hanyoyin sadarwa na bincike na Biochemical da biophysical, 276(2), shafi 534-538.
[x] Renard-Nozaki, J., Kim, T., Imakura, Y., Kihara, M. da Kobayashi, S., 1989. Tasirin alkaloids da aka ware daga Amaryllidaceae akan cutar ta herpes simplex.Bincike a cikin ilimin halittu, 140, shafi 115-128.
[xi] Ieven, M., Vlietinick, AJ, Berghe, DV, Totte, J., Dommisse, R., Esmans, E. da Alderweireldt, F., 1982. Shuka magungunan rigakafi.III.Ware alkaloids daga Clivia miniata Regel (Amaryl-lidaceae).Jaridar Abubuwan Halitta, 45 (5), shafi 564-573.
[xii] Wu, CY, Jan, JT, Ma, SH, Kuo, CJ, Juan, HF, Cheng, YSE, Hsu, HH, Huang, HC, Wu, D., Brik, A. da Liang, FS, 2004 . Kananan kwayoyin da ke yin niyya ga coronavirus ɗan adam.Abubuwan da aka gabatar na Kwalejin Kimiyya na Kasa, 101 (27), pp.10012-10017.
[xiii] Wen, CC, Kuo, YH, Jan, JT, Liang, PH, Wang, SY, Liu, HG, Lee, CK, Chang, ST, Kuo, CJ, Lee, SS da Hou, CC, 2007. Specific. Tsirrai terpenoids da lignoids suna da ayyuka masu ƙarfi na rigakafin cutar kanjamau daga cutar sankarau mai tsanani.Jaridar magungunan magani, 50 (17), shafi 4087-4095.
[xiv] McCutcheon, AR, Roberts, TE, Gibbons, E., Ellis, SM, Babiuk, LA, Hancock, REW da Hasumiyar Tsaro, GHN, 1995. Binciken Antiviral na shuke-shuken magani na British Columbian.Jaridar Ethnopharmacology, 49 (2), shafi 101-110.
[xv] Jassim, SAA da Naji, MA, 2003. Novel antiviral agents: hangen nesa shuka magani.Jaridar amfani da ƙwayoyin cuta, 95 (3), pp.412-427.
[xvi] Luo, H., Tang, QL, Shang, YX, Liang, SB, Yang, M., Robinson, N. da Liu, JP, 2020 -19)?Bita na litattafan tarihi, shaidar bincike da shirye-shiryen rigakafi na yanzu.Jaridar Sinanci na Magungunan Haɗin Kai, shafi 1-8.
Kamar yadda aka saba da kusan dukkanin rukunin yanar gizon ƙwararru, rukunin yanar gizon mu yana amfani da kukis, waɗanda ƙananan fayiloli ne waɗanda aka sauke zuwa na'urarka, don haɓaka ƙwarewar ku.
Wannan daftarin aiki ya bayyana irin bayanan da suke tattarawa, yadda muke amfani da su da kuma dalilin da yasa wasu lokuta muna buƙatar adana waɗannan kukis.Za mu kuma raba yadda za ku iya hana waɗannan kukis ɗin adanawa duk da haka wannan na iya raguwa ko 'karya' wasu abubuwan ayyukan rukunin yanar gizon.
Muna amfani da kukis don dalilai iri-iri dalla-dalla a ƙasa.Abin takaici, a mafi yawan lokuta babu daidaitattun zaɓuɓɓukan masana'antu don kashe kukis ba tare da kashe cikakken aiki da fasalulluka da suke ƙarawa a rukunin yanar gizon ba.Ana ba da shawarar cewa ku bar duk kukis idan ba ku da tabbacin ko kuna buƙatar su ko a'a, idan ana amfani da su don samar da sabis ɗin da kuke amfani da su.
Kuna iya hana saitin kukis ta hanyar daidaita saitunan akan burauzar ku (duba zaɓin "Taimako" na burauzar ku akan yadda ake yin wannan).Ku sani cewa kashe kukis na iya shafar ayyukan wannan da sauran gidajen yanar gizon da kuke ziyarta.Don haka, ana ba da shawarar kada ku kashe kukis.
A wasu lokuta na musamman kuma muna amfani da kukis da amintattun wasu kamfanoni suka bayar.Gidan yanar gizonmu yana amfani da [Google Analytics] wanda shine ɗayan mafi yaɗuwa kuma amintaccen mafita na nazari akan gidan yanar gizo don taimaka mana fahimtar yadda kuke amfani da rukunin da hanyoyin da zamu iya inganta ƙwarewar ku.Waɗannan kukis na iya bin abubuwa kamar tsawon lokacin da kuka kashe akan rukunin yanar gizon da shafukan da kuka ziyarta don mu ci gaba da samar da abun ciki mai jan hankali.Don ƙarin bayani kan kukis na Google Analytics, duba shafin Google Analytics na hukuma.
Google Analytics kayan aikin bincike ne na Google wanda ke taimakawa gidan yanar gizon mu don fahimtar yadda baƙi ke hulɗa da kadarorin su.Yana iya amfani da saitin kukis don tattara bayanai da bayar da rahoton kididdigar amfani da gidan yanar gizon ba tare da tantance kowane maziyartan Google ba.Babban kuki da Google Analytics ke amfani dashi shine kuki '__ga'.
Baya ga ba da rahoton kididdigar amfani da gidan yanar gizon, ana iya amfani da Google Analytics, tare da wasu kukis ɗin talla, don taimakawa nuna tallace-tallacen da suka fi dacewa akan kaddarorin Google (kamar Google Search) da cikin gidan yanar gizo da kuma auna hulɗa tare da tallan da Google ke nunawa. .
Amfani da Adireshin IP.Adireshin IP lambar lamba ce wacce ke gano na'urarka akan Intanet.Za mu iya amfani da adireshin IP ɗinku da nau'in burauza don taimakawa nazarin tsarin amfani da gano matsalolin kan wannan gidan yanar gizon da inganta sabis ɗin da muke ba ku.Amma ba tare da ƙarin bayani Adireshin IP naka baya bayyana ku a matsayin mutum ɗaya ba.
Zabinku.Lokacin da kuka shiga wannan gidan yanar gizon, an aika kukis ɗin mu zuwa mai binciken gidan yanar gizon ku kuma an adana shi akan na'urar ku.Ta amfani da gidan yanar gizon mu, kun yarda da amfani da kukis da fasaha iri ɗaya.
Da fatan bayanan da ke sama sun fayyace muku abubuwa.Kamar yadda aka ambata a baya, idan ba ku da tabbacin ko kuna so ku ƙyale kukis ɗin ko a'a, yawanci yana da aminci a bar kukis kunna idan ya yi hulɗa da ɗaya daga cikin abubuwan da kuke amfani da su a rukunin yanar gizonmu.Koyaya, idan har yanzu kuna neman ƙarin bayani, to ku ji daɗin tuntuɓar mu ta imel a [email protected]
Ya kamata a kunna kuki ɗin da ake buƙata ta musamman a kowane lokaci domin mu iya adana abubuwan da kuke so don saitunan kuki.
Idan kun kashe wannan kuki, ba za mu iya adana abubuwan da kuke so ba.Wannan yana nufin cewa duk lokacin da kuka ziyarci wannan gidan yanar gizon kuna buƙatar sake kunnawa ko kashe kukis.
Lokacin aikawa: Afrilu-18-2020